|Year : 2020 | Volume
| Issue : 1 | Page : 38-41
Comparison of duration of analgesic effect of nalbuphine and morphine as an adjuvant to bupivacaine in the supraclavicular block under ultrasound guidance
Aruna Vengadessane, Jayashri Devi Rajaraman, M. S. Raghuraman, R Krishna Prabu, Srilekha Damodaran, Britto Sabu
Department of Anesthesiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India
|Date of Submission||07-Feb-2020|
|Date of Decision||23-Feb-2020|
|Date of Acceptance||28-Feb-2020|
|Date of Web Publication||22-Jun-2020|
Dr. Jayashri Devi Rajaraman
21, Annai Theresa Street, Raja Nagar, Orleanpet, Puducherry - 605 013
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Although many studies are available in the literature that has analyzed the effects of morphine, nalbuphine, and other opioids, no study had compared the effects of nalbuphine versus morphine as an adjuvant to bupivacaine in the supraclavicular block under the guidance of ultrasound. Methodology: A randomized, double-blinded, prospective study was carried out on 60 patients of the American Society of Anesthesiologists Class I and II who were undergoing upper limb surgeries under the supraclavicular block. Patients were randomly allocated into two groups (n = 30). Group N received 20 ml of 0.5% bupivacaine with 50 μg.kg−1 of nalbuphine, while Group M received 20 ml of 0.5% bupivacaine with 50 μg.kg−1 of morphine. The characteristics of sensory and motor blocks, hemodynamic changes, duration of analgesia, adverse effects, and analgesic requirements were studied at different time intervals. Results: In Group N, there was a statistically significant reduction in the time of onset of sensory block (9.9 ± 3.0 vs. 12.2 ± 2.6 min, P = 0.002) and motor block (14.4 ± 3.6 vs. 19.4 ± 3.6 min, P = 0.0005). The duration of sensory and motor blockade and duration of analgesia were comparable. There was no statistically significant difference regarding block characteristics and hemodynamic parameters. Conclusion: Nalbuphine when added to bupivacaine as an adjuvant had significantly shortened the time of onset of sensory and motor blockade than morphine. However, the duration of analgesia, sensory and motor blockade of nalbuphine versus morphine were comparable.
Keywords: Brachial plexus block, morphine, nalbuphine, supraclavicular block
|How to cite this article:|
Vengadessane A, Rajaraman JD, Raghuraman MS, Prabu R K, Damodaran S, Sabu B. Comparison of duration of analgesic effect of nalbuphine and morphine as an adjuvant to bupivacaine in the supraclavicular block under ultrasound guidance. Anesth Essays Res 2020;14:38-41
|How to cite this URL:|
Vengadessane A, Rajaraman JD, Raghuraman MS, Prabu R K, Damodaran S, Sabu B. Comparison of duration of analgesic effect of nalbuphine and morphine as an adjuvant to bupivacaine in the supraclavicular block under ultrasound guidance. Anesth Essays Res [serial online] 2020 [cited 2020 Jul 12];14:38-41. Available from: http://www.aeronline.org/text.asp?2020/14/1/38/287392
| Introduction|| |
For upper limb surgeries, one of the regional anesthetic techniques usually performed is the supraclavicular brachial plexus block. This block is performed at the level of trunks of the brachial plexus. The motor, sensory, and sympathetic fibers for the upper extremity are carried here. The nerves are enclosed in a sheath of fascia from the neck to axilla. To avoid the undesired effects of general anesthesia, the supraclavicular block is preferred as an alternative.
Different techniques are used to perform the blockade like blind technique which relies on the surface landmark and positioning, nerve stimulator, and ultrasound-guided technique. Ultrasound increases the success rate and reduces the injury to adjacent structures as well as nerve injuries. Besides, it has reduced the systemic toxicities of local anesthetic as the usage of ultrasound has minimized the volume of local anesthetic solutions used in the brachial plexus blocks.
Although the operative condition is good while we use a plain local anesthetic, the duration of postoperative analgesia is shorter. Hence, various adjuvants are used to improve the duration of analgesia while reducing the dose and incidence of adverse reactions related to local anesthetics.
We have compared the efficacy of analgesia and analgesic duration of action of nalbuphine, an agonist-antagonist opioid, and morphine, a pure agonist opioid, as adjuvants to bupivacaine. Although there are some studies in which morphine and nalbuphine were added with local anesthetics individually in the peripheral nerve blocks,, to our knowledge, no study is available in the literature that had compared nalbuphine versus morphine as adjuvants to bupivacaine in the supraclavicular block. Hence, we took this study to analyze the effects of nalbuphine versus morphine as an adjuvant in the supraclavicular block.
| Methodology|| |
With the approval of the Institutional Ethical Committee, a total of 60 patients were randomly allocated into either of the two groups, named M and N. Patients, aged between 18 and 65 years with physical status of the American Society of Anesthesiologists (ASA) Class I and II of both sexes scheduled for surgeries around the elbow, forearm, and hand were enrolled in this study after obtaining the written and informed consent. Patients who have local site skin infections, psychiatric illness, coagulopathies, known allergies, and physical status ASA Class III and above were excluded from the study. Patients who satisfied the inclusion criteria were allotted to M or N group through the computer-generated randomization method. Group M patients received 20 ml of 0.5% bupivacaine with 50 μg.kg−1 of morphine made as 1 ml and given as a total volume of 21 ml and patients in Group N received 20 ml of 0.5% bupivacaine with 50 μg.kg−1 of nalbuphine made as 1 ml, thus a total volume of 21 ml [Flow Chart 1].
Under strict aseptic precautions with the guidance of ultrasound (SIEMENS ACUSON P300 machine with linear probe 10–12 MHz), 1–2 ml of local anesthetic is injected into the skin 1 cm lateral to the transducer. The supraclavicular block for elbow, forearm, and hand surgeries was performed after verifying the needle position and eliminating the intravascular needle placement. Anesthesia provider who was not aware of the local anesthetic mixture, deposited the drug over the brachial plexus after identifying the structures [Figure 1]. The sensory and motor blockade onset was checked with the 3-point scale method (0 = no sensory loss; 1 = no sensation to pinprick; and 2 = no touch sensation) and modified Bromage scale method (0 = normal muscle function; 1 = ability to move elbow; 2 = ability to move wrist; and 3 = complete block with inability to move fingers), respectively. The onset time was calculated from the cessation of drug administration to Grade 2 level blockade for the sensory component and Grade 3 level blockade for the motor component of the block. Intraoperatively, hemodynamic and respiratory parameters were also monitored.
|Figure 1: Supraclavicular brachial plexus (marked as BP in yellow color) seen slightly superficial and posterolateral to the subclavian artery. The brachial plexus is enveloped by a connective tissue sheath. This picture, taken from one of our study cases, clearly shows the intimate location of the pleura and lung to the brachial plexus and subclavian artery. MSM = Middle scalene muscle. The local anesthetic drug mixture was deposited precisely over the plexus under ultrasound guidance in all the study cases|
Click here to view
The duration of sensory blockade was taken from the time of onset of sensory block until the pain reported first, whereas the duration of motor block was calculated from the onset of motor blockade up to complete mobility of the arm. Postoperatively, the pain was assessed with the help of the Numeric Rating Scale (1–10). Patients were also monitored for the side effects such as nausea, vomiting, and allergic reactions.
The IBM SPSS statistics software version 23.0, South Asia, was used to analyze the collected data. For the categorical variables, frequency analysis and percentage analysis were used; the mean and standard deviation were used for the continuous variables. The bivariate samples' significant difference in independent groups was analyzed using the unpaired sample t-test. The categorical data significance was analyzed using the Chi-square test. The probability value of 0.05 for both of the above statistical tools was considered as significant.
| Results|| |
Demographic data of both the groups were comparable [Table 1].
The time of onset of sensory and motor block was significant in Group N compared to Group M. The onset of sensory and motor block in Group N was 9.9 ± 3.0 min and 14.4 ± 3.6 min, respectively, whereas in Group M, it was 12.2 ± 2.6 min and 19.4 ± 3.6 min with P = 0.002 and P = 0.0005, respectively. The duration of sensory block was 508.3 ± 124.2 min in Group N and 490 ± 75.8 min in Group M with P = 0.493 [Table 2]. The duration of motor block was 482.6 ± 124.6 min in Group N and was 472 ± 83.9 min in Group M with P = 0.700. The duration of sensory and motor blockade was statistically insignificant between the two groups [Table 2]. The side effects such as nausea, vomiting, and pruritus were also comparable between the two groups [Table 3].
|Table 2: Parameters studied (onset of sensory, motor blockade, and duration of sensory and motor blockade)|
Click here to view
| Discussion|| |
The supraclavicular block is one of the techniques preferred for surgeries in the upper limb, which was once described as “spinal of the arm.” As it has got a high incidence of complications such as pneumothorax it was not favored previously, but with the use of ultrasound-guided technique, it has resurged. The usage of ultrasound guidance has resulted in the lesser local anesthetic volume requirement and has more success rate because of the accurate delineation of the structures. In our study, we did not encounter any failure as we ensured the local anesthetic spread in all cases by ultrasound guidance.
The local anesthetic as a single injection can provide analgesia only for a limited period. The use of adjuvants such as opioids, magnesium sulfate, and steroids may shorten the onset with an increase in the duration of analgesia. Here, morphine, a pure agonistic opioid and nalbuphine, an agonist–antagonist are compared for the duration of action on adding to 20 ml of 0.5% bupivacaine in the supraclavicular block through ultrasound guidance.
In our study, the duration of analgesia and motor blockade are comparable between the two groups. However, the onset of both sensory and motor blockade was significantly shortened in the nalbuphine group (Group N). Neal et al. observed that the complications associated with a supraclavicular block such as nerve injury, vascular puncture, and hemi-diaphragmatic paresis were reduced significantly under the ultrasound guidance. Similarly, in our study, these complications were avoided because all the blocks were performed under ultrasound guidance. A prospective study on the ultrasound-guided supraclavicular block was conducted by Sáinz López et al. in which they concluded that there was a significant reduction in the requirement of local anesthetic volume. In our study too, we have used only 20 ml of 0.5% of bupivacaine with 50 μg.kg−1 of nalbuphine or morphine made as 21 ml of total volume.
Zeng et al. conducted a meta-analysis on comparing the analgesic effects and safety between morphine and nalbuphine in different routes of administration such as intravenous, intrathecal, and intramuscular in which they concluded that the analgesic effect of nalbuphine was similar to morphine. However, the side effects such as pruritus, nausea, and vomiting were observed more in the morphine group. In accordance with this meta-analysis, our study also observed that the analgesic effects of morphine and nalbuphine in the plexus block were comparable. Nevertheless, in contrast to that meta-analysis, the side effects between nalbuphine and morphine were also comparable in our study which could be probably due to the site of injection (plexus block). In a prospective, randomized, double-blinded study, a significant reduction in the onset of sensory and motor blockade was observed by Nazir and Jain when comparing 30 ml of 0.375% bupivacaine and 30 ml of 0.375% bupivacaine with 1 ml (10 mg) of nalbuphine. Furthermore, there was an enhancement in the duration of analgesia and motor blockade. However, in our study, we observed that nalbuphine, even in the lower dose (3–4 mg in 60–80 kg weighing patients), had shortened the onset of sensory and motor blocks when compared to the equipotent dose of morphine. The duration of analgesia is about 7–11 h in the nalbuphine group of our study, which is in accordance with the study done by Gupta et al., where the duration of analgesia was about 7–9 h in the nalbuphine group. However, they used 10 mg of nalbuphine (versus saline) as an adjuvant to 0.5% bupivacaine while we have used 50 μg.kg−1 in this study. Abdelhaq and Adly Elramely observed that, the duration of analgesia, sensory, and motor blockade had increased with the addition of 20 mg of nalbuphine to 25 ml of 0.5% bupivacaine in the supraclavicular block than plain 25 ml of 0.5% bupivacaine. However, the duration of analgesia was slightly lesser in the nalbuphine group of our study when compared to Abdelhaq and Adly Elramely (7–11 h vs. 13–15 h) which could be attributed to the lower doses used in our study. Furthermore, the “ceiling effect” could be the reason for no further increment in the duration of analgesia proportionate to the doses used by Abdelhaq and Adly Elramely.
Ilham et al. conducted a randomized study in the supraclavicular block and observed that 30 ml of 0.5% plain bupivacaine had significantly reduced the onset of sensory and motor blockade when compared to 30 ml of 0.5% plain levobupivacaine. Jain et al. observed that the duration of sensory and motor blockade was prolonged on adding 0.3 mg of buprenorphine in 30 ml of 0.5% of ropivacaine when compared to the placebo group in the supraclavicular block.
Saryazdi et al. conducted a prospective, randomized, double-blinded study comparing morphine, buprenorphine, pethidine, and fentanyl as an adjuvant to lidocaine in the axillary block. They concluded that the duration and quality of block were better in morphine or pethidine than fentanyl or buprenorphine. However, in our study, the duration of analgesia, sensory, and motor blockade was comparable between nalbuphine and morphine as an adjuvant to bupivacaine. On comparing buprenorphine and morphine with 0.5% bupivacaine in the brachial plexus block, Viel et al. observed that the quality and duration of analgesia were superior in the buprenorphine group. Nonetheless, in our study, the duration of analgesia between morphine and nalbuphine was comparable. A study done by Bazin et al. concluded that the duration of analgesia had improved when opioids such as morphine, buprenorphine, and sufentanil were added with the mixture of bupivacaine and lignocaine in the supraclavicular blocks.
Hence, to our knowledge, our study is unique in comparing nalbuphine versus morphine as an adjuvant to bupivacaine in the ultrasound-guided supraclavicular block, besides using the adjuvants on body weight basis, resulting in lower doses of them. We also believe that either morphine or nalbuphine in 50 μg.kg−1 dose can be used as an adjuvant to local anesthetic in the brachial plexus blocks to provide a prolonged duration of analgesia in ambulatory surgeries also.
| Conclusion|| |
The supraclavicular brachial plexus block is a safer alternative to general anesthesia for upper limb surgeries. Due to the advancements in regional anesthesia with the use of ultrasound guidance, it is considered to be safer and more successful than the surface landmark approach. Nalbuphine, when added to bupivacaine, had significantly shortened the time of onset of sensory and motor blockade than morphine. However, the duration of analgesia, sensory and motor blockade of nalbuphine and morphine, are comparable.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Gupta K, Jain M, Gupta PK, Rastogi B, Zuberi A, Pandey MN. Nalbuphine as an adjuvant to 0.5% bupivacaine for ultrasound-guided supraclavicular brachial plexus blockade. Indian J Pain 2016;30:176-80. [Full text]
Admir H. Hadzic's Peripheral Nerve Blocks and Anatomy for Ultrasound-Guided Regional Anesthesia. 2nd
ed. New York: Mcgraw-Hill Professional; 2012.
Das A, RoyBasunia S, Mukherjee A, Biswas H, Biswas R, Mitra T, et al
. Perineural nalbuphine in ambulatory upper limb surgery: A comparison of effects of levobupivacaine with and without nalbuphine as adjuvant in supraclavicular brachial plexus block – A prospective, double-blinded, randomized controlled study. Anesth Essays Res 2017;11:40-6.
] [Full text]
Saryazdi H, Yazdani A, Sajedi P, Aghadavoudi O. Comparative evaluation of adding different opiates (morphine, meperidine, buprenorphine, or fentanyl) to lidocaine in duration and quality of axillary brachial plexus block. Adv Biomed Res 2015;4:232.
] [Full text]
Morgan and Mikhail's Clinical Anesthesiology, 6th ed. McGraw-Hill Education; 2018.
Mukherjee K, Das A, Basunia SR, Dutta S, Mandal P, Mukherjee A. Evaluation of magnesium as an adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study. J Res Pharm Pract 2014;3:123-9. [Full text]
Neal JM, Gerancher JC, Hebl JR, Ilfeld BM, McCartney CJ, Franco CD, et al
. Upper extremity regional anesthesia: Essentials of our current understanding, 2008. Reg Anesth Pain Med 2009;34:134-70.
Sáinz López J, Prat Vallribera A, Seguí Pericas M, Samà Pujolar A, Calleja Abad M, Sabater Recolons J, et al
. Ultrasound-guided supraclavicular brachial plexus block with small volumes of local anesthetic: Technical description and analysis of results. Rev Esp Anestesiol Reanim 2006;53:400-7.
Zeng Z, Lu J, Shu C, Chen Y, Guo T, Wu QP, et al
. A comparision of nalbuphine with morphine for analgesic effects and safety: Meta-analysis of randomized controlled trials. Sci Rep 2015;5:10927.
Nazir N, Jain S. Randomized controlled trial for evaluating the analgesic effect of nalbuphine as an adjuvant to bupivacaine in supraclavicular block under ultrasound guidance. Anesth Essays Res 2017;11:326-9.
] [Full text]
Abdelhaq M, Adly Elramely M. Effect of nalbuphine as adjuvant to bupivacaine for ultrasound-guided supraclavicular brachial plexus block. Open J Anesthesiol 2016;6:20-6.
Ilham C, Bombaci E, Yurtlu S, Çolakoǧlu S. Efficiency of levobupivacaine and bupivacaine for supraclavicular block: A randomized double-blind comparative study. Braz J Anesthesiol 2014;64:177-82.
Jain N, Khare A, Khandelwal S, Mathur P, Singh M, Mathur V. Buprenorphine as an adjuvant to 0.5% ropivacaine for ultrasound-guided supraclavicular brachial plexus block: A randomized, double-blind, prospective study. Indian J Pain 2017;31:112-8. [Full text]
Viel EJ, Eledjam JJ, De La Coussaye JE, D'Athis F. Brachial plexus block with opioids for postoperative pain relief: Comparison between buprenorphine and morphine. Reg Anesth 1989;14:274-8.
Bazin JE, Massoni C, Bruelle P, Fenies V, Groslier D, Schoeffler P. The addition of opioids to local anaesthetics in brachial plexus block: The comparative effects of morphine, buprenorphine and sufentanil. Anaesthesia 1997;52:858-62.
[Table 1], [Table 2], [Table 3]